The Pharmaceutical logistics Market was valued at USD 94.6 billion in 2023 and is expected to reach USD 210.18 billion by 2032, growing at a CAGR of 9.28% over the forecast period 2024-2032.
The Pharmaceutical Logistics Market report provides key statistical insights and trends shaping the industry. It examines incidence and prevalence rates and highlights regional disease burdens that affect logistics demand. The report analyzes prescription trends by geographic regions, which impacts supply chain needs. It tracks drug volume trends, such as changes in who produces and distributes drugs, especially generics and biologics. Logistics with healthcare spending government, insurer and patient expenditures. Shifting our focus, an article on cold chain logistics investigates the growth of temperature-sensitive drugs and improvements in storage and monitoring technology. The report also looks at the impact of regulatory compliance trends, such as GDP guidelines and serialization mandates, on supply chains. This knowledge assists various stakeholders in effectively managing the changing dynamics of pharmaceutical logistics. The growing demand for pharmaceutical products and rigid regulations drive the pharmaceutical logistics market.
Drivers:
Increasing demand for temperature-sensitive pharmaceuticals necessitates advanced cold chain logistics to maintain product efficacy.
The increasing demand for temperature-sensitive drugs is one of the major drivers that increase the growth in the pharmaceutical logistics industry. In 2022, cold storage medicines made up 35% of the pharmaceutical market, compared to 26% in 2017. The trend has been upward and is expected to continue, with about half of all new medicines predicted to need to be stored and managed with cold storage and distribution in the next five years. To meet this increasing demand, companies are strengthening their cold chain logistics operations. As an example, UPS announced in September 2024 that it was going to acquire Germany-based healthcare logistics businesses Frigo-Trans and BPL. Known for providing temperature-controlled logistics services for pharmaceuticals, this strategic purchase aligns with UPS's goal to establish a strong presence in Europe.
Advances in technology are also greatly necessary in addressing these demands. With the advent of Internet of Things (IoT) devices and Artificial Intelligence (AI) in logistics, advanced solutions provide real-time monitoring and predictive analytics to make cold chain systems more robust and efficient. These technologies allow to forecast risks and control temperature to maintain optimal storage conditions; as a result, you will not lose products due to temperature excursions anymore. Furthermore, research published in January 2025 introduced a novel storage method that could maintain the stability of protein-based drugs and vaccines without refrigeration. This approach, using a solution of perfluorocarbon oil and a surfactant, could eliminate the need for cold storage altogether, particularly in parts of the world where a reliable refrigerator is not a feasible option.
Restraint:
Complex and stringent regulatory guidelines across different regions increase operational costs and complicate compliance for pharmaceutical logistics providers.
Complex and stringent regulatory guidelines across the globe, increased operational costs, and compliance challenges are major challenges faced by the pharmaceutical logistics sector. For example, In the United States, the Drug Supply Chain Security Act (DSCSA) requires pharmaceutical companies to implement electronic, serialized, and interoperable systems that enable them to track and trace prescription drugs through the entire supply chain, with a compliance deadline of November 27, 2023. Furthermore, the EU has approximately 200 Good Distribution Practice (GDP) inspections per year, with a compliance failure rate between 5-15%. Such strict regulations require significant investment in advanced tracking systems and process overhauls, significantly increasing operational costs. In addition, with the absence of centralized, digital, single-window clearance systems in countries such as India, it also leads to slowdown and inefficacy. Contract drug manufacturers in India said that lengthy approval processes and regulatory requirements for some raw material imports typically prompt them to take 8 to 15 days to begin the project, while their Chinese counterparts can do it in three days. Pharmaceutical logistics providers have to deal with financial and time escalations from outsourced partners and regulatory complexities that are daunting enough for an entire industry.
Opportunity:
Integration of advanced technologies like AI, IoT, and telematics enhances supply chain efficiency, offering real-time data analytics and monitoring to ensure product integrity.
Pharmaceutical logistics can greatly benefit from the innovation of advanced technology like Artificial Intelligence (AI), the Internet of Things (IoT), and telematics. According to a recent report, 80% of companies are adopting automated transportation technologies to digitize their workflows and reduce human error. By embracing automation, this transition is projected to optimize processes, reduce the need for manual interventions, and enhance the overall precision of logistics operations. AI has provided invaluable entrees in the field of logistics, producing a 15% reduction of logistics costs, 35% optimization in stock holding, and a 65% increase in the service level. Such innovations are especially vital in the pharmaceutical industry, where systematic stock control and on-time deliveries are necessary to maintain medical products on demand and effective when you use them.
Similarly, more than 80% of logistics firms are looking for IoT integration to enable real-time tracking, optimization of inventory, and loss prevention. During pharmaceutical logistics, IoT devices can check environmental conditions like temperature and humidity during transit, confirming sensitive goods retain integrity in the supply chain. Moreover, companies adopting this technology have reported a 30% reduction in its supply chain disruptions due to the adoption of virtual models as a digital twin to simulate real-world processes. Pharmaceutical companies create digital representations of logistics networks to simulate potential points of failure and optimize routes and storage conditions, which improves the reliability and efficiency of their operations.
Challenge:
Geopolitical tensions and global supply chain disruptions, such as rising sea freight costs and container shortages, hinder the timely delivery of pharmaceutical products.
The pharmaceutical logistics industry is currently subject to enormous external challenges in global supply chains, in particular, rapidly climbing sea freight costs and an acute shortage of containers. Overall disruptions to global supply chains rose 38% in 2024 versus 2023, with labor disruptions up 47% year over year. These disruptions have led to increased freight rates; for instance, the Drewry World Container Index reported an average rate of $5,736 per 40-foot container, significantly higher than the pre-pandemic average of $1,420 in 2019.
These challenges are compounded by geopolitical tensions. The Red Sea crisis is one example; it caused a 90% decline in container shipping via the region between December 2023 and February 2024 as ships were required to redirect via the Cape of Good Hope. routes. Each detour took about 10 days and $1 million in fuel costs per voyage. These disruptions also cascade through the supply chain to the timely delivery of pharmaceutical products, leading to potential shortages and higher operating costs. Labor disputes are also adding to the volatility. A possible strike by 45,000 union workers at U.S. East and Gulf Coast ports threatened to affect approximately half of the nation’s ocean imports, which would impact pharmacy products, among other things. Such actions can cause significant delays and higher shipping costs, which could be passed down to consumers.
By Type
The cold chain logistics segment is expected to account for a notable market share, owing to its vital contribution to storing and delivering temperature-sensitive pharmaceuticals effectively. In a country like India, the cold chain logistics market is on an upswing, owing to government initiatives and consumer awareness, which further bolsters the prominence of this segment. For example, the Indian government has made it a policy to improve cold storage facilities, thereby attracting investments in this area, which has strengthened the infrastructure for vaccines and biologics. In 2023, the cold chain logistics market in India was valued at $14.49 billion due to increasing demand across the pharmaceutical and agriculture sectors. The requirement of perfect temperature control during the supply chain operations to keep the products effective necessitates pharmaceutical cold chain logistics service. The advent of innovative technologies, including virtual "control towers" and IoT monitoring devices, is streamlining cold chain logistics by making shipment tracking and orchestration more efficient and reliable than ever with real-time data.
By Component
The storage segment dominated and accounted for a significant market share of 62% in 2023, largely owing to the rising need for generic and branded pharmaceutical products. This demand requires large storage facilities to maintain the efficacy of the product post-production and during distribution. The storage segment of the market is further bolstered by the laws put down by government bodies regarding the integrity of the products. For instance, strict guidelines on storage by organizations like the U.S. Food and Drug Administration (FDA) for pharmaceuticals ensure that the products are stored under suitable conditions, thus fuelling the demand for specialized storage facilities. The segment is also driven by emerging storage technologies specifically automated warehouses, which not only enhance efficiency but also reduce errors. The expansion in storage facilities with digital solutions and automation of work also benefits the segment growth due to improved inventory management and decreasing operational costs.
In 2023, Europe held the largest market share for pharmaceutical logistics due to the region's strong pharmaceutical sector and reliable logistics infrastructure. Analysts point to the region's robust regulatory standards and high demand for drug products as further evidence of its continued market dominance. Europe commanded more than 37% of the global market share, led by powerhouses such as Germany, the United Kingdom, and France. Conversely, the Asia Pacific region represents the fastest growing market, owing to rapid economic growth and rising demand for over-the-counter (OTC) medicines. The growth in the region is driven by expanding healthcare infrastructure and precedent by governments to improve logistic capabilities, especially in India and China. India accounted for a significant share of the Asia Pacific region. In addition, strict government regulations and improvements in healthcare infrastructure, which are necessary for the safe and efficient distribution of pharmaceutical products, are also driving the growth of this region.
Key Service Providers/Manufacturers
UPS Healthcare (Temperature-Controlled Logistics, Clinical Trials Logistics)
DHL Supply Chain (Life Sciences & Healthcare Logistics, Temperature Management Solutions)
FedEx HealthCare Solutions (SenseAware Monitoring, Cold Chain Shipping)
Kuehne + Nagel (KN PharmaChain, KN PharmaChain GxP Compliant Warehousing)
DB Schenker (DB SCHENKERlife+, DB SCHENKERlife+ Temperature)
CEVA Logistics (CEVA Pharma & Healthcare, Temperature Sensitive Solutions)
C.H. Robinson (Temperature Controlled Logistics, Supply Chain Solutions)
Panalpina (PanCool, PanSafe)
Expeditors International (Temperature Controlled Transport, Cold Chain Solutions)
Agility Logistics (Pharma Logistics, Temperature-Controlled Distribution)
Cardinal Health (OptiFreight Logistics, Medical Distribution Solutions)
McKesson Corporation (Pharmaceutical Distribution, Specialty Drug Distribution)
AmerisourceBergen (Pharmaceutical Distribution, Specialty Logistics)
Sinopharm Logistics (Pharmaceutical Distribution, Cold Chain Logistics)
GEODIS (Pharma Logistics, Temperature-Controlled Transport)
DSV Panalpina (DSV Pharma, Temperature-Controlled Solutions)
Nippon Express (Pharma Logistics, Temperature-Controlled Transport)
Kerry Logistics (Pharmaceutical Logistics, Cold Chain Solutions)
Yusen Logistics (Pharma Gateway, Temperature-Controlled Solutions)
Bolloré Logistics (Pharmaceutical Logistics, Temperature-Controlled Transport)
Recent Developments
In January 2024, DHL Supply Chain dedicated its Norbond facility to expand its pharmaceutical temperature-sensitive logistics network in North America. The company invested in new cold storage facilities and advanced tracking devices to enhance the supply chain management of biopharmaceuticals and vaccines.
In November 2023, FedEx Express expanded its pharmaceutical Priority Alert service to include enhanced visibility and intervention capabilities. This effort is designed to alleviate supply chain disruptions via tracking and proactive response measures.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 94.6 Billion |
| Market Size by 2032 | USD 210.18 Billion |
| CAGR | CAGR of 9.28% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Cold Chain Logistics, Non-cold Chain Logistics) • By Component (Storage, Transportation, Monitoring Components) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | UPS Healthcare, DHL Supply Chain, FedEx HealthCare Solutions, Kuehne + Nagel, DB Schenker, CEVA Logistics, C.H. Robinson, Panalpina, Expeditors International, Agility Logistics, Cardinal Health, McKesson Corporation, AmerisourceBergen, Sinopharm Logistics, GEODIS, DSV Panalpina, Nippon Express, Kerry Logistics, Yusen Logistics, Bolloré Logistics. |
Ans. The projected market size for the pharmaceutical logistics Market is USD 210.18 Billion by 2032.
Ans. The CAGR of the Pharmaceutical logistics Market is 9.28% during the forecast period of 2024-2032.
Ans: The Europe region dominated the pharmaceutical logistics Market in 2023.
Ans: Integration of advanced technologies like AI, IoT, and telematics enhances supply chain efficiency, offering real-time data analytics and monitoring to ensure product integrity.
Ans: The Storage segment dominated the pharmaceutical logistics Market.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Pharmaceutical Drug Volume: Production & Distribution Trends
5.2 Healthcare Spending on Pharmaceutical Logistics (2023)
5.3 Cold Chain Logistics & Temperature-Sensitive Drug Transport
5.4 Regulatory & Compliance Trends in Pharmaceutical Logistics
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Pharmaceutical logistics Market Segmentation, By Type
7.1 Chapter Overview
7.2 Cold Chain Logistics
7.2.1 Cold Chain Logistics Market Trends Analysis (2020-2032)
7.2.2 Cold Chain Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Non-cold Chain Logistics
7.3.1 Non-cold Chain Logistics Market Trends Analysis (2020-2032)
7.3.2 Non-cold Chain Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Pharmaceutical logistics Market Segmentation, By Component
8.1 Chapter Overview
8.2 Storage
8.2.1 Storage Market Trends Analysis (2020-2032)
8.2.2 Storage Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 Warehouse
8.2.3.1 Warehouse Market Trends Analysis (2020-2032)
8.2.3.2 Warehouse Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Refrigerated Container
8.2.4.1 Refrigerated Container Market Trends Analysis (2020-2032)
8.2.4.2 Refrigerated Container Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Transportation
8.3.1 Transportation Market Trends Analysis (2020-2032)
8.3.2 Transportation Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.3 Overland Logistics
8.3.3.1 Overland Logistics Market Trends Analysis (2020-2032)
8.3.3.2 Overland Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.4 Sea Freight Logistics
8.3.4.1 Sea Freight Logistics Market Trends Analysis (2020-2032)
8.3.4.2 Sea Freight Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3.5 Airfreight Logistics
8.3.5.1 Airfreight Logistics Market Trends Analysis (2020-2032)
8.3.5.2 Airfreight Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Monitoring Components
8.4.1 Monitoring Components Market Trends Analysis (2020-2032)
8.4.2 Monitoring Components Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.3 Hardware
8.4.3.1 Hardware Market Trends Analysis (2020-2032)
8.4.3.2 Hardware Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.3.3 Sensors
8.4.3.3.1 Sensors Market Trends Analysis (2020-2032)
8.4.3.3.2 Sensors Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.3.4 Networking Devices
8.4.3.4.1 Networking Devices Market Trends Analysis (2020-2032)
8.4.3.4.2 Networking Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.3.5 RFID Devices
8.4.3.5.1 RFID Devices Market Trends Analysis (2020-2032)
8.4.3.5.2 RFID Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.3.6 Telematics
8.4.3.6.1 Telematics Market Trends Analysis (2020-2032)
8.4.3.6.2 Telematics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4.4 Software
8.4.4.1 Software Market Trends Analysis (2020-2032)
8.4.4.2 Software Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.2.4 North America Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.2.5.2 USA Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.2.6.2 Canada Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.6.2 France Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.5.2 China Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.5.2 India Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.5.2 Japan Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.9.2 Australia Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.2.4 Africa Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Pharmaceutical logistics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.6.4 Latin America Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Pharmaceutical logistics Market Estimates and Forecasts, By Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Pharmaceutical logistics Market Estimates and Forecasts, By Component (2020-2032) (USD Billion)
10. Company Profiles
10.1 UPS Healthcare
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 DHL Supply Chain
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 FedEx HealthCare Solutions
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Kuehne + Nagel
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 DB Schenker
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 CEVA Logistics
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 C.H. Robinson
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Panalpina
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Expeditors International
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Agility Logistics
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Cold Chain Logistics
Non-cold Chain Logistics
By Component
Storage
Warehouse
Refrigerated Container
Transportation
Overland Logistics
Sea Freight Logistics
Airfreight Logistics
Monitoring Components
Hardware
Sensors
Networking Devices
RFID Devices
Telematics
Software
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Digestive Health Supplements Market Size was valued at USD 51.65 Billion in 2023 and is expected to reach USD 111.96 Billion by 2032 and grow at a CAGR of 9.42% over the forecast period 2024-2032.
Drug Testing Market was valued at USD 13.41 billion in 2023 and is expected to reach USD 21.30 billion by 2032, growing at a CAGR of 5.29% from 2024-2032.
The Breast Imaging Market size was estimated at USD 5.00 billion in 2023 and is expected to reach USD 10.59 billion by 2032 with a growing CAGR of 8.7% during the forecast period of 2024-2032.
The Smart Bandages Market was valued at USD 767.6 million in 2023 and is expected to reach USD 2111.5 million in 2032 and grow at a CAGR of 11.9% over the forecast period of 2024-2032.
Cell Freezing Media Market was valued at $ 152.14 billion in 2023 and is expected to reach $ 333.29 billion by 2032, growing at a CAGR of 9.15% from 2024-2032.
The HIV Drugs Market size was valued at USD 32.7 Bn in 2023 and is estimated to reach USD 44.56 Bn by 2032 with a growing CAGR of 3.5% Over the Forecast Period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
